Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures
e.l.f. Beauty ELF) Has a Tariff Problem—But It’s Betting Gen Z and Hailey Bieber Can Fix It !
e.l.f. Beauty closed FY25 with 28% net sales growth and 26% adjusted EBITDA expansion, marking its 25th straight quarter of revenue and share gains—underscoring both execution strength and brand durability. Gross margin improved to 71%, free cash flow nearly doubled to $115M, and U.S. market share rose another 190bps, while international sales surged 60% YoY, now comprising ~20% of revenue. The acquisition of Rhode for $1B signals a pivotal move into premium, Gen Z-aligned skincare with high DTC traction and low retail saturation—set for Sephora rollout across three key markets. With strong aided awareness upside and deliberate brand autonomy, rhode could meaningfully expand e.l.f.’s TAM and operational leverage. Meanwhile, Naturium and e.l.f. SKIN continue to gain in mass skincare, and a $1 SKU-wide price increase in August reflects judicious monetization. However, tariffs—impacting 75% of China-based sourcing at a 55% effective rate—pose a $50M COGS headwind and remain the primary margin overhang, especially as no formal FY26 outlook was issued. Mitigation strategies include pricing, sourcing shifts, and mix rebalancing. Early Q1 momentum and rhode’s integration trajectory suggest reacceleration is plausible, but can e.l.f. navigate tariff headwinds and premium integration simultaneously without compromising its value-led growth flywheel?
